Market Overview:
The global drug eluting sinus stent (DESS) market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic sinusitis, rising awareness about DESS among physicians and patients, and technological advancements in DESS devices. Based on type, the global drug eluting sinus stent (DESS) market is segmented into corticosteroid-eluting stents, silicon resin-eluting stents, and other types of eluting stents. The corticosteroid-eluting segment is expected to account for the largest share of the global DESS market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to factors such as rising prevalence of chronic rhinosinusitis and increasing adoption rates for corticosteroid-eluting sinus stents by physicians worldwide. Based on application, the global drug eluting sinus stent (DESS) market is divided into hospital applications, clinic applications, and other applications segments. In 2018, hospital applications are estimated to account for majority share (~64%)of total revenue generated by application segments owing high adoption rates across developed countries coupled with growing number os hospitals globally .
 Industry Outlook.svg)
Product Definition:
A drug eluting sinus stent (DESS) is a small, wire mesh tube that is inserted into the nose to open and keep open an obstructed sinus passage. A DESS typically contains a drug that is slowly released from the stent over time, which helps to prevent obstruction of the sinus passage again.
Corticosteroid:
Corticosteroid is a type of medication that reduces the inflammation response by decreasing the production of cytokines. Cytokines are proteins that act as messengers between cells in the immune system and help them to communicate with each other. The reduction in cytokine levels helps to reduce swelling and redness of skin, decrease joint pain, reduce muscle weakness, improve breathing and increase energy level among other functions.
Silicon Resin:
Silicon resin is a type of solid polymer and is derived from silica. It has various properties such as hardness, color, and electrical resistivity. Silicon resins are used in the manufacturing of DESS owing to their excellent mechanical strength, low friction coefficient, high tensile strength and flexibility among others.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and others. The other applications include emergency room, operating room and hospital floor. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of cardiovascular diseases that require surgical intervention for treating. Moreover, increasing R&D activities by various companies for developing new products with better efficacy & safety profiles will further boost product demand over the forecast period.
The clinic segment is expected to witness lucrative growth during the forecast period due to rising geriatric population base that requires regular check-ups and an increase in number of cardiovascular disease patients seeking medical treatment at clinics & hospitals across countries such as India & China where DESS are used as a staple therapy for preventing complications arising from hardening of arteries resulting from atherosclerosis or any other related conditions which involves usage of stents available in the market today along with proper diagnosis by Cardiology Specialists (i.e., cardiologists).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing incidence of sinusitis and growing number of FDA approvals for novel drug eluting stents. Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 owing to rapidly improving healthcare infrastructure, rising prevalence of chronic diseases, and availability of less expensive generic drugs. Moreover, government initiatives aimed at reducing healthcare expenditure are anticipated favorably impact industry growth in this region.
Growth Factors:
- Increasing incidence of sinusitis: The incidence of sinusitis is increasing globally due to changing lifestyles and environmental factors. This will lead to an increase in the demand for DESSs, as they are the most effective treatment for this condition.
- Growing awareness about DESSs: There is a growing awareness among physicians and patients about the benefits of DESSs over other treatments for sinusitis. This is likely to drive the growth of the market in coming years.
- Technological advancements: The manufacturers are constantly innovating and bringing new technologies to the market, which will help improve patient outcomes with DESSs. This will spur growth in the market over time.
- Rising healthcare expenditure: Countries around the world are increasing their healthcare spending, which will lead to an increase in demand for medical devices such as DESSs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Eluting Sinus Stent (DESS) Market Research Report
By Type
Corticosteroid, Silicon Resin, Other
By Application
Hospital, Clinic, Other
By Companies
Intersect ENT,Inc., Medtronic Plc, Stryker Corporation, Johnson＆Johnson, Intersect ENT,Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Drug Eluting Sinus Stent (DESS) Market Report Segments:
The global Drug Eluting Sinus Stent (DESS) market is segmented on the basis of:
Types
Corticosteroid, Silicon Resin, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Intersect ENT,Inc.
- Medtronic Plc
- Stryker Corporation
- Johnson＆Johnson
- Intersect ENT,Inc.
 Market Overview.svg)
Highlights of The Drug Eluting Sinus Stent (DESS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroid
- Silicon Resin
- Other
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Eluting Sinus Stent (DESS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A drug eluting sinus stent (DESS) is a medical device that helps to keep the airways open in people with obstructive sleep apnea. The device is inserted into the nose through the mouth and down into the throat. It releases a small amount of medication over time, which helps to open up blocked airways during sleep.
Some of the key players operating in the drug eluting sinus stent (dess) market are Intersect ENT,Inc., Medtronic Plc, Stryker Corporation, Johnson＆Johnson, Intersect ENT,Inc..
The drug eluting sinus stent (dess) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Eluting Sinus Stent (DESS) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Eluting Sinus Stent (DESS) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Eluting Sinus Stent (DESS) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Eluting Sinus Stent (DESS) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Eluting Sinus Stent (DESS) Market Size & Forecast, 2018-2028
4.5.1 Drug Eluting Sinus Stent (DESS) Market Size and Y-o-Y Growth
4.5.2 Drug Eluting Sinus Stent (DESS) Market Absolute $ Opportunity
Chapter 5 Global Drug Eluting Sinus Stent (DESS) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Eluting Sinus Stent (DESS) Market Size Forecast by Type
5.2.1 Corticosteroid
5.2.2 Silicon Resin
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Eluting Sinus Stent (DESS) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Eluting Sinus Stent (DESS) Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Eluting Sinus Stent (DESS) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Eluting Sinus Stent (DESS) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Eluting Sinus Stent (DESS) Analysis and Forecast
9.1 Introduction
9.2 North America Drug Eluting Sinus Stent (DESS) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Eluting Sinus Stent (DESS) Market Size Forecast by Type
9.6.1 Corticosteroid
9.6.2 Silicon Resin
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Eluting Sinus Stent (DESS) Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Eluting Sinus Stent (DESS) Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Eluting Sinus Stent (DESS) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Eluting Sinus Stent (DESS) Market Size Forecast by Type
10.6.1 Corticosteroid
10.6.2 Silicon Resin
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Eluting Sinus Stent (DESS) Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Eluting Sinus Stent (DESS) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Eluting Sinus Stent (DESS) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Eluting Sinus Stent (DESS) Market Size Forecast by Type
11.6.1 Corticosteroid
11.6.2 Silicon Resin
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Eluting Sinus Stent (DESS) Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Eluting Sinus Stent (DESS) Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Eluting Sinus Stent (DESS) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Eluting Sinus Stent (DESS) Market Size Forecast by Type
12.6.1 Corticosteroid
12.6.2 Silicon Resin
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Eluting Sinus Stent (DESS) Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Eluting Sinus Stent (DESS) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Eluting Sinus Stent (DESS) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Eluting Sinus Stent (DESS) Market Size Forecast by Type
13.6.1 Corticosteroid
13.6.2 Silicon Resin
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Eluting Sinus Stent (DESS) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Eluting Sinus Stent (DESS) Market: Competitive Dashboard
14.2 Global Drug Eluting Sinus Stent (DESS) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Intersect ENT,Inc.
14.3.2 Medtronic Plc
14.3.3 Stryker Corporation
14.3.4 Johnson＆Johnson
14.3.5 Intersect ENT,Inc.
